Supplementary Figure 10 shows the differential abundance and pathway enrichment analyses based on KRAS mutations. (A) Volcano plot displaying the differentially abundant proteins between KRAS mutant PDA and KRAS wild-type PDA. (B) Pathways enriched in Gene Ontology molecular function database from upregulated proteins in tumors that harbored KRAS mutations.